Fatty Acid Amide Hydrolase as a Potential Therapeutic Target for the Treatment of Pain and CNS Disorders

Expert Opinion on Drug Discovery - United Kingdom
doi 10.1517/17460440903018857
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

Informa Healthcare

Related search

The Potential of Oxytocin as a Therapeutic Target for Psychiatric Disorders

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation

Balkan Medical Journal
Medicine
2014English

Fatty Acid Amide Hydrolase Inhibition for the Symptomatic Relief of Parkinson’s Disease

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2016English

Exploring the Fatty Acid Amide Hydrolase and Cyclooxygenase Inhibitory Properties of Novel Amide Derivatives of Ibuprofen

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2020English

Parabens Inhibit Fatty Acid Amide Hydrolase: A Potential Role in Paraben-Enhanced 3t3-L1 Adipocyte Differentiation

Toxicology Letters
MedicineToxicology
2016English

Temporal Changes in Mouse Brain Fatty Acid Amide Hydrolase Activity

Neuroscience
Neuroscience
2009English

A Second Fatty Acid Amide Hydrolase With Variable Distribution Among Placental Mammals

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Role of Steroids on the Membrane Binding Ability of Fatty Acid Amide Hydrolase

Cannabis and Cannabinoid Research
Alternative MedicinePharmacologyComplementary
2019English

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy